Related Experiment Video
Updated: May 13, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
HLF and PPARα axis regulates metabolic-associated fatty liver disease through extracellular vesicles derived from the
Xingzhen Yang1, Jiale Wang1, Xinyu Qi1
1Guangxi Key Laboratory of Animal Breeding, Disease Control and Prevention, College of Animal Science and Technology Guangxi University Nanning China.
Abstract:
Metabolic-associated fatty liver disease (MAFLD) has become increasingly widespread. The intestine is the primary site of lipid absorption and is important for the homeostasis of lipid metabolism. However, the mechanism underlying the participation of the intestinal tract in the development of MAFLD requires additional investigation. In this study, analysis of the single-cell transcriptome of intestinal tissue from cynomolgus monkeys found that hepatic leukemia factor (HLF) participated in the genetic regulation of intestinal lipid absorption. Results obtained from normal and intestine-specific Hlf-knockout mice confirmed that HLF alleviated intestinal barrier disorders by inhibiting peroxisome proliferator-activated receptor alpha (PPARα) expression. The HLF/PPARα axis alleviated MAFLD by mediating gut microbiota-derived extracellular vesicles (fEVs), thereby inhibiting hepatocyte ferroptosis. Lipidomics and functional experiments verified that taurochenodeoxycholic acid (TCDCA), a conjugated bile acid contained in the fEVs, had a key role in the process. In conclusion, intestinal HLF activity was mediated by fEVs and identified as a novel therapeutic target for MAFLD.
Insights
Hepatic leukemia factor (HLF) in the intestine alleviates metabolic-associated fatty liver disease (MAFLD) by regulating lipid absorption and gut microbiota. This pathway involves extracellular vesicles and taurochenodeoxycholic acid, offering a new therapeutic target for MAFLD.
Area of Science:
- Gastroenterology and Hepatology
- Molecular Biology
- Metabolic Disorders
Background:
- Metabolic-associated fatty liver disease (MAFLD) prevalence is rising globally.
- The intestine plays a crucial role in lipid metabolism and homeostasis.
- Mechanisms linking intestinal function to MAFLD pathogenesis require further elucidation.
Purpose of the Study:
- To investigate the role of hepatic leukemia factor (HLF) in intestinal lipid absorption and MAFLD development.
- To identify the molecular pathways and mediators involved in HLF's effect on MAFLD.
Main Methods:
- Single-cell transcriptome analysis of intestinal tissue from cynomolgus monkeys.
- Intestine-specific Hlf-knockout mouse models.
- Lipidomics and functional experiments.
Main Results:
- HLF regulates intestinal lipid absorption and alleviates intestinal barrier dysfunction by inhibiting PPARα expression.
- The HLF/PPARα axis modulates gut microbiota-derived extracellular vesicles (fEVs).
- fEVs containing taurochenodeoxycholic acid (TCDCA) inhibit hepatocyte ferroptosis, ameliorating MAFLD.
Conclusions:
- Intestinal HLF activity, mediated by fEVs and TCDCA, is a novel mechanism in MAFLD pathogenesis.
- HLF represents a potential therapeutic target for managing MAFLD.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid Digestion
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Cell Specific Gene Expression

